Novo Nordisk's surprise CEO departure amid mounting competitive pressures and disappointing clinical results has accelerated the stock's 50% decline since mid-2024.
NextNRG Inc. reported strong growth in April 2025, with revenue up 154% and fuel delivery volumes up 207%. This reflects the success of their AI-driven energy and mobility solutions.
Lifting and material handling equipment company Terex (NYSE:TEX) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 4.9% year on year to $1.23 billion. On the other hand, the company’s full-year revenue guidance of $5.4 billion at the midpoint came in 2.2% above analysts’ estimates. Its GAAP profit of $0.31 per share was 28.8% below analysts’ consensus estimates.
Plug Power shares rose 3% to 72 cents on Friday, clawing back some ground after a sharp selloff earlier in the week. The stock remains down 21.4% since Monday's session following a mixed Q1 earnings report.
Lendr.fi on Friday introduced a decentralized platform that lets investors gain on-chain exposure to real-world assets like real estate, ETFs and commodities, combined with liquid staking, a structure that adds passive yield while preserving asset owner
The U.S. President stated that Treasury Secretary Scott Bessent and Commerce Secretary Howard Lutnick will send letters indicating what their trade partners will pay to do business in the United States.
Manufacturing services provider Proto Labs (NYSE:PRLB) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.3% year on year to $126.2 million. The company expects next quarter’s revenue to be around $128 million, close to analysts’ estimates. Its non-GAAP profit of $0.33 per share was 13.3% above analysts’ consensus estimates.
Health insurance company Cigna (NYSE:CI) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 14.4% year on year to $65.5 billion. Its non-GAAP profit of $6.74 per share was 6.2% above analysts’ consensus estimates.
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 11.7% year on year to $2.88 billion. The company’s full-year revenue guidance of $12.25 billion at the midpoint came in 2.5% above analysts’ estimates. Its non-GAAP profit of $0.19 per share was significantly above analysts’ consensus estimates.
